ClinicoEconomics and Outcomes Research
Volume 13, 2021 - Issue
Original Research
A Cost Effectiveness Analysis of Rivaroxaban Compared to Warfarin for Deep Vein Thrombosis (DVT) Treatment in Ethiopia
Manaye Tamrie Derseh1 Departement of Pharmaceutics and Social Pharmacy, School of Pharmacy, College of Medicine and Health Sciences, Mizan-Tepi University, Mizan-Aman, EthiopiaCorrespondence[email protected]
https://orcid.org/0000-0002-8632-748XView further author information
https://orcid.org/0000-0002-8632-748XView further author information, , , , Ashagrachew Tewabe Yayehrad4 Department of Pharmacy, College of Medicine and Health Sciences, Bahir Dar University, Bahir Dar, Ethiopiahttps://orcid.org/0000-0001-5122-7684View further author information
https://orcid.org/0000-0001-5122-7684View further author information & Abyou Seyfu Ambaye1 Departement of Pharmaceutics and Social Pharmacy, School of Pharmacy, College of Medicine and Health Sciences, Mizan-Tepi University, Mizan-Aman, Ethiopiahttps://orcid.org/0000-0002-1598-8395View further author information
https://orcid.org/0000-0002-1598-8395View further author information